| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 2 | 2022 | 335 | 1.150 |
Why?
|
| Immunoglobulin E | 2 | 2024 | 159 | 1.150 |
Why?
|
| Allergens | 3 | 2024 | 245 | 1.110 |
Why?
|
| Models, Molecular | 17 | 2016 | 1070 | 0.850 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2022 | 21 | 0.820 |
Why?
|
| Microbiota | 4 | 2021 | 392 | 0.730 |
Why?
|
| Gastrointestinal Microbiome | 7 | 2022 | 680 | 0.680 |
Why?
|
| Bacterial Toxins | 4 | 2014 | 176 | 0.670 |
Why?
|
| Behcet Syndrome | 1 | 2019 | 16 | 0.650 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 4 | 2008 | 12 | 0.630 |
Why?
|
| Dysbiosis | 1 | 2019 | 120 | 0.600 |
Why?
|
| Enterotoxins | 3 | 2014 | 82 | 0.600 |
Why?
|
| Clostridium Infections | 5 | 2022 | 234 | 0.560 |
Why?
|
| Protein Conformation | 10 | 2013 | 836 | 0.490 |
Why?
|
| Gastrointestinal Tract | 3 | 2019 | 208 | 0.470 |
Why?
|
| Proteins | 5 | 2016 | 1038 | 0.440 |
Why?
|
| Measles virus | 5 | 2012 | 10 | 0.410 |
Why?
|
| Antitoxins | 1 | 2012 | 8 | 0.400 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2022 | 227 | 0.380 |
Why?
|
| Bacterial Proteins | 3 | 2017 | 879 | 0.370 |
Why?
|
| Irritable Bowel Syndrome | 3 | 2019 | 206 | 0.340 |
Why?
|
| Bifidobacterium | 2 | 2021 | 63 | 0.310 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2008 | 43 | 0.300 |
Why?
|
| Magnesium | 2 | 2008 | 120 | 0.300 |
Why?
|
| Hemagglutinins, Viral | 4 | 2011 | 25 | 0.290 |
Why?
|
| Feces | 9 | 2022 | 710 | 0.280 |
Why?
|
| DNA Repair | 2 | 2007 | 581 | 0.270 |
Why?
|
| Chromatography, Liquid | 3 | 2022 | 191 | 0.260 |
Why?
|
| Bacteria | 5 | 2022 | 482 | 0.250 |
Why?
|
| Myosin Type V | 1 | 2025 | 9 | 0.240 |
Why?
|
| Amino Acid Sequence | 13 | 2014 | 2698 | 0.240 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 3 | 2010 | 43 | 0.240 |
Why?
|
| Multifactorial Inheritance | 1 | 2025 | 137 | 0.230 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2022 | 93 | 0.230 |
Why?
|
| Hydrogen Bonding | 3 | 2016 | 79 | 0.220 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2022 | 372 | 0.220 |
Why?
|
| Horse Diseases | 1 | 2023 | 31 | 0.220 |
Why?
|
| Light | 1 | 2023 | 175 | 0.210 |
Why?
|
| DNA | 2 | 2008 | 1592 | 0.210 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2022 | 32 | 0.210 |
Why?
|
| Molecular Sequence Data | 12 | 2010 | 3871 | 0.200 |
Why?
|
| Interleukin-4 | 1 | 2022 | 139 | 0.200 |
Why?
|
| Protein Structure, Tertiary | 6 | 2014 | 752 | 0.200 |
Why?
|
| Amino Acid Motifs | 4 | 2008 | 199 | 0.200 |
Why?
|
| Hypersensitivity | 1 | 2024 | 182 | 0.190 |
Why?
|
| Humans | 32 | 2025 | 123157 | 0.190 |
Why?
|
| Ligands | 2 | 2016 | 533 | 0.190 |
Why?
|
| Intestine, Small | 1 | 2024 | 302 | 0.190 |
Why?
|
| Colon | 1 | 2024 | 353 | 0.190 |
Why?
|
| Food Hypersensitivity | 1 | 2024 | 149 | 0.180 |
Why?
|
| Neurotransmitter Agents | 1 | 2021 | 139 | 0.180 |
Why?
|
| Crohn Disease | 1 | 2024 | 283 | 0.180 |
Why?
|
| Systems Biology | 1 | 2020 | 58 | 0.180 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2025 | 314 | 0.180 |
Why?
|
| Bacteriological Techniques | 1 | 2020 | 91 | 0.170 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 422 | 0.170 |
Why?
|
| Environment | 1 | 2020 | 143 | 0.170 |
Why?
|
| Histidine | 1 | 2019 | 72 | 0.170 |
Why?
|
| Viral Proteins | 3 | 2014 | 348 | 0.170 |
Why?
|
| Measles | 2 | 2011 | 32 | 0.170 |
Why?
|
| Poliovirus | 3 | 2010 | 47 | 0.170 |
Why?
|
| Chloride Channels | 1 | 2019 | 62 | 0.160 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2002 | 359 | 0.160 |
Why?
|
| Databases, Protein | 3 | 2008 | 55 | 0.160 |
Why?
|
| Conserved Sequence | 4 | 2008 | 293 | 0.150 |
Why?
|
| Cysteine Proteases | 2 | 2014 | 7 | 0.150 |
Why?
|
| Calibration | 3 | 2023 | 88 | 0.150 |
Why?
|
| Propane | 1 | 2017 | 28 | 0.140 |
Why?
|
| Glyceraldehyde | 1 | 2017 | 28 | 0.140 |
Why?
|
| Virus Internalization | 2 | 2023 | 54 | 0.140 |
Why?
|
| Glycerol | 1 | 2017 | 90 | 0.140 |
Why?
|
| Sequence Alignment | 4 | 2010 | 623 | 0.140 |
Why?
|
| Antigens, CD | 4 | 2008 | 420 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2025 | 3083 | 0.140 |
Why?
|
| Genetic Variation | 1 | 2024 | 1480 | 0.140 |
Why?
|
| Evolution, Molecular | 1 | 2020 | 672 | 0.140 |
Why?
|
| Epitopes | 2 | 2008 | 430 | 0.140 |
Why?
|
| Visceral Pain | 1 | 2016 | 7 | 0.140 |
Why?
|
| Receptors, Virus | 2 | 2008 | 104 | 0.130 |
Why?
|
| Protein Binding | 8 | 2016 | 1743 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 3 | 2021 | 2397 | 0.130 |
Why?
|
| Genomics | 2 | 2020 | 1477 | 0.130 |
Why?
|
| Abdominal Pain | 4 | 2022 | 307 | 0.130 |
Why?
|
| Binding Sites | 7 | 2009 | 1292 | 0.130 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2016 | 167 | 0.130 |
Why?
|
| Protein Stability | 2 | 2013 | 166 | 0.120 |
Why?
|
| Texas | 1 | 2024 | 3547 | 0.120 |
Why?
|
| Single-Domain Antibodies | 1 | 2014 | 9 | 0.120 |
Why?
|
| Protein Multimerization | 2 | 2012 | 122 | 0.120 |
Why?
|
| Peptides | 2 | 2010 | 796 | 0.120 |
Why?
|
| Probiotics | 1 | 2017 | 208 | 0.120 |
Why?
|
| Glucosyltransferases | 1 | 2014 | 44 | 0.120 |
Why?
|
| Genotype | 1 | 2020 | 2540 | 0.120 |
Why?
|
| Vancomycin | 2 | 2017 | 217 | 0.120 |
Why?
|
| Virulence Factors | 2 | 2014 | 172 | 0.120 |
Why?
|
| Virus Integration | 1 | 2014 | 42 | 0.110 |
Why?
|
| Immunoglobulins | 2 | 2005 | 168 | 0.110 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2014 | 93 | 0.110 |
Why?
|
| Macromolecular Substances | 1 | 2014 | 185 | 0.110 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2014 | 112 | 0.110 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2014 | 62 | 0.110 |
Why?
|
| Animals | 15 | 2023 | 33723 | 0.110 |
Why?
|
| Virus Attachment | 2 | 2011 | 41 | 0.110 |
Why?
|
| ADAM Proteins | 1 | 2014 | 79 | 0.110 |
Why?
|
| Child | 6 | 2025 | 24225 | 0.110 |
Why?
|
| DNA Glycosylases | 1 | 2013 | 32 | 0.110 |
Why?
|
| Receptors, Cell Surface | 4 | 2008 | 469 | 0.100 |
Why?
|
| Kinetics | 4 | 2008 | 1313 | 0.100 |
Why?
|
| Metabolomics | 3 | 2022 | 409 | 0.100 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 191 | 0.100 |
Why?
|
| Escherichia coli Proteins | 1 | 2014 | 303 | 0.100 |
Why?
|
| Glycoproteins | 2 | 2005 | 369 | 0.100 |
Why?
|
| Protein Folding | 1 | 2013 | 218 | 0.100 |
Why?
|
| Software | 3 | 2007 | 677 | 0.100 |
Why?
|
| Infant | 2 | 2025 | 12339 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2008 | 657 | 0.100 |
Why?
|
| Viral Fusion Proteins | 1 | 2012 | 77 | 0.100 |
Why?
|
| Protein Interaction Mapping | 2 | 2013 | 85 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 251 | 0.100 |
Why?
|
| Child, Preschool | 2 | 2025 | 13880 | 0.100 |
Why?
|
| Catalysis | 2 | 2008 | 125 | 0.090 |
Why?
|
| Cysteine | 2 | 2011 | 133 | 0.090 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2011 | 159 | 0.090 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 774 | 0.090 |
Why?
|
| Metronidazole | 1 | 2012 | 155 | 0.090 |
Why?
|
| Male | 9 | 2025 | 60040 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 1760 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2023 | 424 | 0.090 |
Why?
|
| Phenotype | 1 | 2020 | 4221 | 0.090 |
Why?
|
| Adolescent | 3 | 2025 | 19095 | 0.090 |
Why?
|
| Uracil Nucleotides | 1 | 2010 | 17 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2025 | 2585 | 0.090 |
Why?
|
| HIV-1 | 1 | 2014 | 465 | 0.090 |
Why?
|
| Colitis | 1 | 2012 | 152 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2008 | 317 | 0.080 |
Why?
|
| Alleles | 1 | 2014 | 1604 | 0.080 |
Why?
|
| Diarrhea | 1 | 2012 | 315 | 0.080 |
Why?
|
| Brain | 2 | 2021 | 2947 | 0.080 |
Why?
|
| Lithocholic Acid | 1 | 2009 | 2 | 0.080 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2009 | 59 | 0.080 |
Why?
|
| Genome, Viral | 2 | 2006 | 171 | 0.080 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 2008 | 7 | 0.080 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2008 | 75 | 0.080 |
Why?
|
| Virus Shedding | 1 | 2008 | 79 | 0.080 |
Why?
|
| Sequence Analysis, Protein | 1 | 2007 | 49 | 0.070 |
Why?
|
| Female | 7 | 2025 | 65444 | 0.070 |
Why?
|
| Membrane Fusion | 2 | 2005 | 38 | 0.070 |
Why?
|
| Temperature | 1 | 2008 | 306 | 0.070 |
Why?
|
| Diet | 1 | 2014 | 1125 | 0.070 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 4 | 2008 | 6 | 0.070 |
Why?
|
| Phylogeny | 2 | 2020 | 685 | 0.070 |
Why?
|
| Uridine | 1 | 2006 | 34 | 0.070 |
Why?
|
| Picornaviridae | 1 | 2006 | 20 | 0.070 |
Why?
|
| Vero Cells | 3 | 2014 | 110 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1528 | 0.070 |
Why?
|
| Ribonucleoproteins | 1 | 2006 | 62 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2024 | 15998 | 0.060 |
Why?
|
| Fermentation | 2 | 2017 | 64 | 0.060 |
Why?
|
| Cytokines | 1 | 2011 | 1283 | 0.060 |
Why?
|
| Amino Acids | 1 | 2008 | 650 | 0.060 |
Why?
|
| Distemper Virus, Canine | 1 | 2005 | 3 | 0.060 |
Why?
|
| Tyrosine | 2 | 2021 | 152 | 0.060 |
Why?
|
| Metalloproteases | 1 | 2005 | 14 | 0.060 |
Why?
|
| Intestines | 2 | 2021 | 571 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2019 | 425 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 288 | 0.060 |
Why?
|
| Internet | 1 | 2007 | 378 | 0.060 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2006 | 193 | 0.060 |
Why?
|
| Mutation | 5 | 2011 | 5773 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2007 | 637 | 0.060 |
Why?
|
| Mice | 5 | 2022 | 17487 | 0.060 |
Why?
|
| Asthma | 1 | 2011 | 746 | 0.060 |
Why?
|
| Spectrophotometry | 1 | 2023 | 58 | 0.060 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2023 | 44 | 0.060 |
Why?
|
| Horses | 1 | 2023 | 89 | 0.050 |
Why?
|
| Age of Onset | 1 | 2025 | 581 | 0.050 |
Why?
|
| Epithelial Cells | 2 | 2023 | 900 | 0.050 |
Why?
|
| Deoxyribonuclease I | 1 | 2002 | 49 | 0.050 |
Why?
|
| Substrate Specificity | 3 | 2010 | 284 | 0.050 |
Why?
|
| Germ-Free Life | 1 | 2022 | 59 | 0.050 |
Why?
|
| Steroid Hydroxylases | 1 | 2002 | 20 | 0.050 |
Why?
|
| Microsomes | 1 | 2002 | 55 | 0.050 |
Why?
|
| Technology | 1 | 2023 | 65 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2002 | 100 | 0.050 |
Why?
|
| Drug Design | 2 | 2016 | 147 | 0.050 |
Why?
|
| Software Design | 1 | 2002 | 24 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2023 | 1390 | 0.050 |
Why?
|
| Mentha piperita | 1 | 2022 | 9 | 0.050 |
Why?
|
| Chemokines, CC | 1 | 2002 | 28 | 0.050 |
Why?
|
| Bacteroidetes | 1 | 2022 | 20 | 0.050 |
Why?
|
| Automation | 1 | 2002 | 59 | 0.050 |
Why?
|
| Plant Oils | 1 | 2022 | 32 | 0.050 |
Why?
|
| Bifidobacteriales Infections | 1 | 2021 | 4 | 0.050 |
Why?
|
| Adult | 2 | 2019 | 29034 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 262 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 414 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 240 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2023 | 184 | 0.050 |
Why?
|
| Amino Acid Substitution | 3 | 2011 | 389 | 0.050 |
Why?
|
| Algorithms | 1 | 2007 | 1595 | 0.040 |
Why?
|
| Cell Line | 2 | 2016 | 2774 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2021 | 338 | 0.040 |
Why?
|
| Organoids | 1 | 2022 | 276 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2020 | 184 | 0.040 |
Why?
|
| Cholesterol | 1 | 2002 | 525 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 2024 | 0.040 |
Why?
|
| Virulence | 2 | 2011 | 262 | 0.040 |
Why?
|
| Biological Transport | 1 | 2019 | 347 | 0.040 |
Why?
|
| Computational Biology | 1 | 2004 | 800 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 459 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2019 | 304 | 0.040 |
Why?
|
| Uridine Triphosphate | 2 | 2010 | 11 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 142 | 0.040 |
Why?
|
| Genome | 1 | 2021 | 472 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2020 | 234 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 798 | 0.040 |
Why?
|
| Recurrence | 1 | 2022 | 1422 | 0.040 |
Why?
|
| Base Sequence | 2 | 2016 | 3093 | 0.040 |
Why?
|
| Mitochondria | 1 | 2002 | 678 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2017 | 54 | 0.040 |
Why?
|
| Metabolome | 1 | 2019 | 292 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 1116 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 1134 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2017 | 171 | 0.030 |
Why?
|
| CHO Cells | 2 | 2008 | 159 | 0.030 |
Why?
|
| Models, Chemical | 1 | 2016 | 86 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2016 | 239 | 0.030 |
Why?
|
| Cricetinae | 2 | 2008 | 410 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2008 | 327 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 2047 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 1416 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2009 | 617 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 481 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 285 | 0.030 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2014 | 39 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2014 | 49 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2017 | 362 | 0.030 |
Why?
|
| Virus Replication | 2 | 2010 | 604 | 0.030 |
Why?
|
| ADAM10 Protein | 1 | 2014 | 10 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2014 | 3047 | 0.030 |
Why?
|
| Methane | 1 | 2014 | 12 | 0.030 |
Why?
|
| Hydrogen | 1 | 2014 | 38 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 198 | 0.030 |
Why?
|
| Scattering, Small Angle | 1 | 2013 | 8 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 2013 | 58 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1211 | 0.030 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 26 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2014 | 477 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2012 | 98 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 56 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3251 | 0.020 |
Why?
|
| S-Nitrosothiols | 1 | 2011 | 4 | 0.020 |
Why?
|
| Phytic Acid | 1 | 2011 | 10 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2011 | 96 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 6028 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2008 | 3277 | 0.020 |
Why?
|
| Ileum | 1 | 2011 | 132 | 0.020 |
Why?
|
| Disulfides | 1 | 2011 | 78 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 793 | 0.020 |
Why?
|
| Uridine Monophosphate | 1 | 2010 | 8 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2010 | 179 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 740 | 0.020 |
Why?
|
| Rats | 1 | 2016 | 3631 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1387 | 0.020 |
Why?
|
| Coumarins | 1 | 2009 | 23 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2009 | 71 | 0.020 |
Why?
|
| Haplorhini | 1 | 2008 | 123 | 0.020 |
Why?
|
| World Health Organization | 1 | 2008 | 111 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2011 | 432 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 809 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 170 | 0.020 |
Why?
|
| Callithrix | 1 | 2008 | 10 | 0.020 |
Why?
|
| Isoleucine | 1 | 2008 | 27 | 0.020 |
Why?
|
| Species Specificity | 1 | 2009 | 549 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 354 | 0.020 |
Why?
|
| Fluorescence | 1 | 2008 | 93 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2008 | 100 | 0.020 |
Why?
|
| Cricetulus | 1 | 2008 | 101 | 0.020 |
Why?
|
| Steroids | 1 | 2009 | 203 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2008 | 90 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2008 | 256 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2008 | 494 | 0.020 |
Why?
|
| Oxidants | 1 | 2006 | 25 | 0.020 |
Why?
|
| Methylamines | 1 | 2006 | 17 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 12116 | 0.020 |
Why?
|
| Ferrets | 1 | 2005 | 14 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 286 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2010 | 744 | 0.010 |
Why?
|
| Aldehyde-Lyases | 1 | 2004 | 4 | 0.010 |
Why?
|
| Hemeproteins | 1 | 2004 | 7 | 0.010 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2004 | 19 | 0.010 |
Why?
|
| Asparagine | 1 | 2004 | 21 | 0.010 |
Why?
|
| Membrane Cofactor Protein | 1 | 2004 | 10 | 0.010 |
Why?
|
| Cell Fusion | 1 | 2004 | 38 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2004 | 155 | 0.010 |
Why?
|
| Ribonuclease III | 1 | 2004 | 87 | 0.010 |
Why?
|
| Alanine | 1 | 2004 | 181 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 8865 | 0.010 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2002 | 13 | 0.010 |
Why?
|
| Hydroxylation | 1 | 2002 | 45 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2004 | 347 | 0.010 |
Why?
|
| Point Mutation | 1 | 2004 | 348 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 893 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 1101 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2002 | 979 | 0.010 |
Why?
|